EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis

Oncoscience - United States
doi 10.18632/oncoscience.288
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

Dual Inhibition of Ezh2 and Hdac Is Synergistic in Ezh2 Dysregulated Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors

Nature
Multidisciplinary
2015English

Loss of Hus1 Sensitizes Cells to Etoposide-Induced Apoptosis by Regulating BH3-only Proteins

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Pevonedistat, a Nedd8-Activating Enzyme Inhibitor, Sensitizes Neoplastic B-Cells to Death Receptor-Mediated Apoptosis

Oncotarget
Oncology
2017English

Autophagy Prolongs Survival After NFκB Inhibition in B-Cell Lymphomas

Autophagy
Cell BiologyMolecular Biology
2012English

Flavonoid Quercetin Sensitizes a CD95-resistant Cell Line to Apoptosis by Activating Protein Kinase Cα

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Multidrug Resistance-Associated Protein-Overexpressing Teniposide-Resistant Human Lymphomas Undergo Apoptosis by a Tubulin-Binding Agent

Cancer Research
Cancer ResearchOncology
2008English

Bufalin Sensitizes Human Bladder Carcinoma Cells to TRAIL-mediated Apoptosis

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy